KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-Current Debt: 2011-2020

Historic Non-Current Debt for TherapeuticsMD (TXMD) over the last 5 years, with Dec 2020 value amounting to $237.7 million.

  • TherapeuticsMD's Non-Current Debt fell 27.55% to $171.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $171.7 million, marking a year-over-year decrease of 27.55%. This contributed to the annual value of $237.7 million for FY2020, which is 22.13% up from last year.
  • According to the latest figures from FY2020, TherapeuticsMD's Non-Current Debt is $237.7 million, which was up 22.13% from $194.6 million recorded in FY2019.
  • In the past 5 years, TherapeuticsMD's Non-Current Debt ranged from a high of $237.7 million in FY2020 and a low of $73.4 million during FY2018.
  • Over the past 3 years, TherapeuticsMD's median Non-Current Debt value was $194.6 million (recorded in 2019), while the average stood at $168.6 million.
  • Data for TherapeuticsMD's Non-Current Debt shows a peak YoY surged of 165.24% (in 2019) over the last 5 years.
  • TherapeuticsMD's Non-Current Debt (Yearly) stood at $73.4 million in 2018, then surged by 165.24% to $194.6 million in 2019, then grew by 22.13% to $237.7 million in 2020.